Brief: CorMedix Inc Announces FDA Acceptance Of Resubmission Of New Drug Application For DefenCath
21/06/2023 13:32
June 21 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. ANNOUNCES FDA ACCEPTANCE OF RESUBMISSION OF
NEW
DRUG APPLICATION FOR DEFENCATH
* CORMEDIX INC - PDUFA DATE OF NOVEMBER 15, 2023
Source text for Eikon: ID:nGNX9Xd9Dl
Further company coverage: CRMD.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary